SEC Comment Letter 0000000000-24-005525 to PALISADE BIO, INC. (PALI)
PALISADE BIO, INC.
Date: May 14, 2024 · CIK: 0001357459 · Accession: 0000000000-24-005525
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279222
Letter
United States securities and exchange commission logo May 14, 2024 J.D. Finley Chief Executive Officer Palisade Bio, Inc. 7750 El Camino Real, Suite 2A Carlsbad, CA 92009 Re:Palisade Bio, Inc. Registration Statement on Form S-3 Filed May 8, 2024 File No. 333-279222 Dear J.D. Finley: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Dennis Gluck
Show Raw Text
United States securities and exchange commission logo
May 14, 2024
J.D. Finley
Chief Executive Officer
Palisade Bio, Inc.
7750 El Camino Real, Suite 2A
Carlsbad, CA 92009
Re:Palisade Bio, Inc.
Registration Statement on Form S-3
Filed May 8, 2024
File No. 333-279222
Dear J.D. Finley:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Dennis Gluck